The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome
Open accessAbstract
Budd-Chiari syndrome (BCS) is a rare disorder that is characterized by hepatic venous outflow obstruction. The aim of this study was to assess determinants of survival and to evaluate the effect of portosystemic shunting. In this international multicenter study, 237 patients with BCS, diagnosed between 1984 and 2001, were investigated. Univariate, multivariate, and time-dependent Cox regression analyses were performed. Overall survival at 1, 5, and 10 years was 82% (95% CI, 77%-87%), 69% (95% CI, 62%-76%), and 62% (95% CI, 54%-70%), respectively. Encephalopathy, ascites, prothrombin time, and bilirubin were independent determinants of survival. A prognostic classification combining these factors could identify three classes of patients (classes I-III). The 5-year survival rate was 89% (95% CI, 79%-99%) for class I, 74% (95% CI, 65%-83%) for class II, and 42% (95% CI, 28%-56%) for class III. Anticoagulants were administered to 72%; only for patients in class I was this associated with a trend toward improved survival (relative risk [RR], 0.14; 95% CI, 0.02-1.21). Portosystemic shunting was performed in 49% of the patients (n = 117); only for patients in class II, time-dependent analyses suggested an improved survival (RR, 0.63; 95% CI, 0.26-1.49). In conclusion, at the time of diagnosis, patients with BCS can be classified into good (I), intermediate (II), and poor (III) prognostic classes, according to simple baseline clinical and laboratory parameters. Our results suggest an improved survival after surgical portosystemic shunting for patients with an intermediate prognosis (class II). (Hepatology 2004;39:500-508.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
Denninger, M.-H., Chaït, Y., Casadevall, N., Hillaire, S., Guillin, M.-C., Bezeaud, A., Erlinger, S., Briere, J., & Valla, D. (2000) · Hepatology · doi:10.1002/hep.510310307 · Cited by 686
Self-citationBudd–Chiari syndrome: a review by an expert panel
Janssen, H. L. A., Garcia-Pagan, J.-C., Elias, E., Mentha, G., Hadengue, A., & Valla, D.-C. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00434-8 · Cited by 491
Self-citationJanssen, H. L. A., Meinardi, J. R., Vleggaar, F. P., Uum, S. H. M. V., Haagsma, E. B., van der Meer, F. J. M., van Hattum, J., Chamuleau, R. A. F. M., Adang, R. P. R., Vandenbroucke, J. P., et al. (2000) · PubMed · doi:10.1182/blood.v96.7.2364 · Cited by 380
Self-citationDilawari, J. B., Bambery, P., Chawla, Y. K., Kaur, U., Bhusnurmath, S. R., Malhotra, H. S., Sood, G., MITRA, S. K., KHANNA, S. K., & WALIA, B. S. (1994) · Medicine · doi:10.1097/00005792-199401000-00003 · Cited by 372
Primary Myeloproliferative Disorder and Hepatic Vein Thrombosis
Valla, D. C., Casadevall, N., Lacombe, C., Varet, B. R., GOLDWASSER, E., FRANCO, D., MAILLARD, J.-N., PARIENTE, E. A., Leporrier, M., RUEFF, B., et al. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-3-329 · Cited by 299
Self-citationTanaka, M., & Wanless, I. R. (1998) · Hepatology · doi:10.1002/hep.510270224 · Cited by 263
Zeitoun, G., Escolano, S., Hadengue, A., Azar, N., El Younsi, M., Mallet, A., Boudet, M.-J., Hay, J.-M., Erlinger, S., Benhamou, J.-P., et al. (1999) · Hepatology · doi:10.1002/hep.510300125 · Cited by 242
Self-citationThe first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art
Rössle, M., Siegerstetter, V., Huber, M., & Ochs, A. (1998) · Liver · doi:10.1111/j.1600-0676.1998.tb00132.x · Cited by 241
The changing scene of hepatic vein thrombosis: Recognition of asymptomatic cases
Hadengue, A., Poliquin, M., Vilgrain, V., Belghiti, J., Degott, C., Erlinger, S., & Benhamou, J.-P. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90765-x · Cited by 228
Perelló, A., García-Pagán, J. C., Gilabert, R., Suárez, Y., Moitinho, E., Cervantes, F., Reverter, J. C., Escorsell, A., Bosch, J., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30274 · Cited by 216
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Vascular disorders of the liver # †
DeLeve, L. D., Valla, D.-C., & Garcia-Tsao, G. (2009) · Hepatology · doi:10.1002/hep.22772 · Cited by 978
Self-citationEASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Boyer, T. D., & Haskal, Z. J. (2010) · Hepatology · doi:10.1002/hep.23383 · Cited by 549
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Murad, S. D., Plessier, A., Hernandez-Guerra, M., Fabris, F., Eapen, C. E., Bahr, M. J., Trebicka, J., Morard, I., Lasser, L., Heller, J., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-3-200908040-00004 · Cited by 532
Self-citationThe role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension†
Boyer, T. D., & Haskal, Z. J. (2005) · Hepatology · doi:10.1002/hep.20559 · Cited by 445
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis
Smalberg, J. H., Arends, L. R., Valla, D. C., Kiladjian, J.-J., Janssen, H. L. A., & Leebeek, F. W. G. (2012) · Blood · doi:10.1182/blood-2011-09-376517 · Cited by 377
Self-citationKiladjian, J.-J., Cervantes, F., Leebeek, F. W. G., Marzac, C., Cassinat, B., Chevret, S., Cazals-Hatem, D., Plessier, A., Garcia-Pagan, J.-C., Murad, S. D., et al. (2008) · Blood · doi:10.1182/blood-2007-11-125328 · Cited by 361
Self-citationTIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients
Garcia–Pagán, J. C., Heydtmann, M., Raffa, S., Plessier, A., Murad, S., Fabris, F., Vizzini, G., Abraldes, J. G., Olliff, S., Nicolini, A., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.051 · Cited by 354
Self-citationGood long-term outcome of Budd-Chiari syndrome with a step-wise management
Seijo, S., Plessier, A., Hoekstra, J., Dell'Era, A., Mandair, D., Rifai, K., Trebicka, J., Morard, I., Lasser, L., Abraldes, J. G., et al. (2013) · Hepatology · doi:10.1002/hep.26306 · Cited by 305
Self-citationSquires, R. H., Ng, V., Romero, R., Ekong, U., Hardikar, W., Emre, S., & Mazariegos, G. V. (2014) · Hepatology · doi:10.1002/hep.27191 · Cited by 254
Metadata
- Authors
- Murad, S. D., Valla, D.-C., de Groen, P. C., Zeitoun, G., Hopmans, J. A. M., Haagsma, E. B., van Hoek, B., Hansen, B. E., Rosendaal, F. R., & Janssen, H. L. A.
- Venue
- Hepatology
- Published
- 2004-02
- Volume
- 39
- Issue
- 2
- Pages
- 500-508
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2050437797
- Cited by
- 357
- References
- 25
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.